Nitro-G-L-arginine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNitro-G-L-arginine
Drug Alias NameNG-nitro-L-arginineNO2ARGNOARGL-NNAL-NA
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNitric oxide synthase inhibitors
TargetsNitric oxide synthase
Therapy Area/IndicationsMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A